Flebogamma

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2016
02420032016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The previous studies with Flebogamma® 5 % DIF intravenous immunoglobulin (IVIG) contained insufficient numbers of pediatric… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2014
2014
The effects of intravenous immunoglobulin (IVIG) products are being evaluated in Alzheimer's disease (AD) patients. IVIG contains… (More)
Is this relevant?
2013
2013
Intravenous immunoglobulin (IVIG) products are prepared from plasma immunoglobulins from healthy donors. Pilot studies suggest… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2012
2012
The aim of this study was to determine health care resource utilization and direct medical costs in Spanish patients treated with… (More)
Is this relevant?
2011
2011
  • Maite L Ristol P Jorquera
  • 2011
Background:A recent thromboembolic adverse events outbreak linked to a specific intravenous immunoglobulin (IVIG) brand has… (More)
Is this relevant?
2010
2010
Cognitive improvement in Alzheimer's disease (AD) patients treated with intravenous immunoglobulin (IvIg) has been attributed to… (More)
Is this relevant?
2009
2009
Flebogamma 5% dual inactivation and filtration (DIF), a new 5% liquid intravenous immunoglobulin with a stability of 2 years when… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 3
Is this relevant?
2009
2009
The development of effective, safe, liquid intravenous immunoglobulins (IVIG) preparations has represented a major therapeutic… (More)
Is this relevant?
2004
2004
Antibodies directed against human respiratory syncytial virus (HRSV) from two commercial preparations of human immunoglobulins… (More)
Is this relevant?
2003
2003
Although atopic dermatitis generally responds to topical therapy, small numbers of patients have severe resistant disease despite… (More)
Is this relevant?